Nephrotic Syndrome Secondary to Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits of Lambda Light Chain

Table 2

Treatment recommendation for PGNMID [9].

CKD stage I and II; Proteinuria (<1 g/day); No evidence of progressive disease	CKD stage I and II with high grade proteinuria (>1 g/day); Progressive disease; CKD stage III and IV	CKD stage V
(1) Symptomatic measures only; (2) Careful surveillance	(1) Chemotherapy,; cyclophosphamide, and; bortezomib; (2) HDM/ASCT; (3) Rituximab	(1) Kidney transplantation; (2) HDM/ASCT